155 related articles for article (PubMed ID: 38229544)
1. Suppression of pancreatic cancer proliferation through TXNIP-mediated inhibition of the MAPK signaling pathway.
Fei Q; Jin K; Shi S; Li T; Guo D; Lin M; Yu X; Wu W; Ye L
Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):513-524. PubMed ID: 38229544
[TBL] [Abstract][Full Text] [Related]
2. TXNIP overexpression suppresses proliferation and induces apoptosis in SMMC7221 cells through ROS generation and MAPK pathway activation.
Li J; Yue Z; Xiong W; Sun P; You K; Wang J
Oncol Rep; 2017 Jun; 37(6):3369-3376. PubMed ID: 28440491
[TBL] [Abstract][Full Text] [Related]
3. FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801.
Yamaguchi F; Hirata Y; Akram H; Kamitori K; Dong Y; Sui L; Tokuda M
BMC Cancer; 2013 Oct; 13():468. PubMed ID: 24112473
[TBL] [Abstract][Full Text] [Related]
4. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
[TBL] [Abstract][Full Text] [Related]
5. Hyperglycemia regulates TXNIP/TRX/ROS axis via p38 MAPK and ERK pathways in pancreatic cancer.
Li W; Wu Z; Ma Q; Liu J; Xu Q; Han L; Duan W; Lv Y; Wang F; Reindl KM; Wu E
Curr Cancer Drug Targets; 2014; 14(4):348-56. PubMed ID: 24720336
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-224 Promotes Pancreatic Cancer Cell Proliferation and Migration by Targeting the TXNIP-Mediated HIF1α Pathway.
Zhu G; Zhou L; Liu H; Shan Y; Zhang X
Cell Physiol Biochem; 2018; 48(4):1735-1746. PubMed ID: 30078003
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid ameliorates hepatic stellate cell activation via suppression of thioredoxin interacting protein expression.
Shimizu H; Tsubota T; Kanki K; Shiota G
J Cell Physiol; 2018 Jan; 233(1):607-616. PubMed ID: 28322443
[TBL] [Abstract][Full Text] [Related]
8. 2-Deoxyglucose induces the expression of thioredoxin interacting protein (TXNIP) by increasing O-GlcNAcylation - Implications for targeting the Warburg effect in cancer cells.
Hong SY; Hagen T
Biochem Biophys Res Commun; 2015 Oct; 465(4):838-44. PubMed ID: 26315267
[TBL] [Abstract][Full Text] [Related]
9. Thioredoxin-interacting protein is a favored target of miR-125b, promoting metastasis and progression of pancreatic cancer via the HIF1α pathway.
Wang P; Zheng D; Qi H; Gao Q
J Biochem Mol Toxicol; 2021 Jul; 35(7):e22782. PubMed ID: 33896068
[TBL] [Abstract][Full Text] [Related]
10. Cytokines Regulate β-Cell Thioredoxin-interacting Protein (TXNIP) via Distinct Mechanisms and Pathways.
Hong K; Xu G; Grayson TB; Shalev A
J Biol Chem; 2016 Apr; 291(16):8428-39. PubMed ID: 26858253
[TBL] [Abstract][Full Text] [Related]
11. Txnip C247S mutation protects the heart against acute myocardial infarction.
Nakayama Y; Mukai N; Wang BF; Yang K; Patwari P; Kitsis RN; Yoshioka J
J Mol Cell Cardiol; 2021 Jun; 155():36-49. PubMed ID: 33652022
[TBL] [Abstract][Full Text] [Related]
12. [Over-expression of thioredoxin-interacting protein promotes apoptosis of MIN6 cells via activating p38MAPK pathway].
Deng W; Li Y; Jia Y; Tang L; He Q; Liu D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct; 33(10):1323-1327. PubMed ID: 29169415
[TBL] [Abstract][Full Text] [Related]
13. W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway.
Li T; Lin GY; Zhong L; Zhou Y; Wang J; Zhu Y; Feng Y; Cai XQ; Liu Q; Nosjean O; Boutin JA; Renard P; Yang DH; Wang MW
Acta Pharmacol Sin; 2017 Jul; 38(7):1024-1037. PubMed ID: 28502980
[TBL] [Abstract][Full Text] [Related]
14. Competitive adsorption of microRNA-532-3p by circular RNA SOD2 activates Thioredoxin Interacting Protein/NLR family pyrin domain containing 3 pathway and promotes pyroptosis of non-alcoholic fatty hepatocytes.
Chen F; Xing Y; Chen Z; Chen X; Li J; Gong S; Luo F; Cai Q
Eur J Med Res; 2024 Apr; 29(1):250. PubMed ID: 38659023
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer.
Morrison JA; Pike LA; Sams SB; Sharma V; Zhou Q; Severson JJ; Tan AC; Wood WM; Haugen BR
Mol Cancer; 2014 Mar; 13():62. PubMed ID: 24645981
[TBL] [Abstract][Full Text] [Related]
16. TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression.
Zhang X; Zhao S; Yuan Q; Zhu L; Li F; Wang H; Kong D; Hao J
Cell Death Dis; 2021 Jun; 12(7):642. PubMed ID: 34162834
[TBL] [Abstract][Full Text] [Related]
17. Endogenous hydrogen sulfide-mediated MAPK inhibition preserves endothelial function through TXNIP signaling.
Tian D; Dong J; Jin S; Teng X; Wu Y
Free Radic Biol Med; 2017 Sep; 110():291-299. PubMed ID: 28669627
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin-interacting protein expression is required for VEGF-mediated angiogenic signal in endothelial cells.
Abdelsaid MA; Matragoon S; El-Remessy AB
Antioxid Redox Signal; 2013 Dec; 19(18):2199-212. PubMed ID: 23718729
[TBL] [Abstract][Full Text] [Related]
19. High beta-cell mass prevents streptozotocin-induced diabetes in thioredoxin-interacting protein-deficient mice.
Masson E; Koren S; Razik F; Goldberg H; Kwan EP; Sheu L; Gaisano HY; Fantus IG
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1251-61. PubMed ID: 19223654
[TBL] [Abstract][Full Text] [Related]
20. FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer.
Ji S; Qin Y; Liang C; Huang R; Shi S; Liu J; Jin K; Liang D; Xu W; Zhang B; Liu L; Liu C; Xu J; Ni Q; Chiao PJ; Li M; Yu X
Clin Cancer Res; 2016 Aug; 22(15):3950-60. PubMed ID: 26983463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
